Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Hematology
Disease Category: Stem Cell Transplant
Location: United States, GA

Clinical Trial Details

Overview

Research Study Summary

ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue

Purpose
For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00026312?term=ANBL0032&rank=1
To Learn more

CW ID: 181735
Date Last Changed: May 23, 2014

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Facility Type
N/A

Contact

Patricia Green
Memorial University Medical Center
4700 Waters Avenue
Hoskins Center - 2nd Floor
Savannah, GA 31404
Phone: 912-350-8707

View Map

Research Center Information:

Memorial University Medical Center

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.